(original) (raw)

TY - JOUR AU - Diem, S. AU - Kasenda, B. AU - Spain, L. AU - Martin-Liberal, J. AU - Marconcini, R. AU - Gore, M. AU - Larkin, J. PY - 2016 DA - 2016/02/01 TI - Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma JO - British Journal of Cancer SP - 256 EP - 261 VL - 114 IS - 3 AB - Treatment with programmed death receptor-1 (PD-1) antibodies is associated with high response rates in patients with advanced melanoma. Reliable markers for early response and outcome are still sparse. SN - 1532-1827 UR - https://doi.org/10.1038/bjc.2015.467 DO - 10.1038/bjc.2015.467 ID - Diem2016 ER -